BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2297773)

  • 1. Rate of buthionine sulfoximine entry into brain and xenotransplanted human gliomas.
    Fekete I; Griffith OW; Schlageter KE; Bigner DD; Friedman HS; Groothuis DR
    Cancer Res; 1990 Feb; 50(4):1251-6. PubMed ID: 2297773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of an amino acid-lowering diet on the rate of melphalan entry into brain and xenotransplanted glioma.
    Groothuis DR; Lippitz BE; Fekete I; Schlageter KE; Molnar P; Colvin OM; Roe CR; Bigner DD; Friedman HS
    Cancer Res; 1992 Oct; 52(20):5590-6. PubMed ID: 1394182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
    Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice.
    Skapek SX; Colvin OM; Griffith OW; Elion GB; Bigner DD; Friedman HS
    Cancer Res; 1988 May; 48(10):2764-7. PubMed ID: 3359437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
    Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK
    Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Facilitated" amino acid transport is upregulated in brain tumors.
    Miyagawa T; Oku T; Uehara H; Desai R; Beattie B; Tjuvajev J; Blasberg R
    J Cereb Blood Flow Metab; 1998 May; 18(5):500-9. PubMed ID: 9591842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
    Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM
    Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of DL-buthionine-S,R-sulfoximine on the growth of EMT6 and RIF mouse tumors.
    Miller AC; Henderson BW
    J Natl Cancer Inst; 1986 Aug; 77(2):505-10. PubMed ID: 3461211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts.
    Guichard M; Lespinasse F; Malaise EP
    Radiat Res; 1986 Jan; 105(1):115-25. PubMed ID: 3945723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA; Greene K; Ahmad S; Vistica DT
    Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of enhanced antitumor efficacy for L-buthionine sulfoximine in combination with carmustine, cyclophosphamide, doxorubicin or melphalan in mice.
    Soble MJ; Dorr RT
    Anticancer Res; 1988; 8(1):17-22. PubMed ID: 3358633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion.
    Rosenberg MC; Colvin OM; Griffith OW; Bigner SH; Elion GB; Horton JK; Lilley E; Bigner DD; Friedman HS
    Cancer Res; 1989 Dec; 49(24 Pt 1):6917-22. PubMed ID: 2582434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent measurements of blood flow and transcapillary transport in xenotransplanted human gliomas in immunosuppressed rats.
    Vriesendorp FJ; Peagram C; Bigner DD; Groothuis DR
    J Natl Cancer Inst; 1987 Jul; 79(1):123-30. PubMed ID: 3474439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buthionine sulfoximine-mediated depletion of glutathione in intracranial human glioma-derived xenografts.
    Skapek SX; Colvin OM; Griffith OW; Groothuis DR; Colapinto EV; Lee Y; Hilton J; Elion GB; Bigner DD; Friedman HS
    Biochem Pharmacol; 1988 Nov; 37(22):4313-7. PubMed ID: 3196356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone effects on [125I]albumin distribution in experimental RG-2 gliomas and adjacent brain.
    Nakagawa H; Groothuis DR; Owens ES; Fenstermacher JD; Patlak CS; Blasberg RG
    J Cereb Blood Flow Metab; 1987 Dec; 7(6):687-701. PubMed ID: 3693426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The radiation dose-response relationship in a human glioma xenograft and an evaluation of the influence of glutathione depletion by buthionine sulfoximine.
    Halperin EC; Brizel DM; Honore G; Sontag MR; Griffith OW; Bigner DD; Friedman HS
    Int J Radiat Oncol Biol Phys; 1992; 24(1):103-9. PubMed ID: 1512145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-buthionine-sulfoximine-mediated radiosensitization in experimental interstitial radiotherapy of intracerebral D-54 MG glioma xenografts in athymic mice.
    Lippitz BE; Halperin EC; Griffith OW; Colvin OM; Honore G; Ostertag CB; Bigner DD; Friedman HS
    Neurosurgery; 1990 Feb; 26(2):255-60. PubMed ID: 2308673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
    Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
    Berger SJ; Gosky D; Zborowska E; Willson JK; Berger NA
    Cancer Res; 1994 Aug; 54(15):4077-83. PubMed ID: 8033140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.